JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M301938200 on February 27, 2003

J. Biol. Chem., Vol. 278, Issue 21, 19453-19462, May 23, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/21/19453    most recent
M301938200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, A.
Right arrow Articles by Lynch, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, A.
Right arrow Articles by Lynch, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Activation of p38 Plays a Pivotal Role in the Inhibitory Effect of Lipopolysaccharide and Interleukin-1{beta} on Long Term Potentiation in Rat Dentate Gyrus*

Áine Kelly {ddagger}, Emily Vereker, Yvonne Nolan, Marcella Brady, Claire Barry, Christine E. Loscher §, Kingston H. G. Mills § and Marina A. Lynch

From the Trinity College Institute of Neuroscience, Department of Physiology, Dublin 2, Ireland, § Department of Biochemistry, Trinity College, Dublin 2, Ireland

Lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, has been shown to induce profound changes both peripherally and centrally. It has recently been reported that intraperitoneal injection of LPS inhibited long term potentiation (LTP) in perforant path-granule cell synapses and that this effect was coupled with an increase in the concentration of the proinflammatory cytokine, interleukin-1{beta} (IL-1{beta}). The LPS-induced effects were abrogated by inhibition of caspase-1, suggesting that IL-1{beta} may mediate the effects of LPS. Here we report that the inhibition of LTP induced by LPS and IL-1{beta} was coupled with stimulation of the stress-activated protein kinase p38 in hippocampus and entorhinal cortex and that this effect was abrogated by the p38 inhibitor SB203580, while the effect of LPS was markedly attenuated in C57BL/6 IL-1RI-/- mice. The data also indicate that activation of the transcription factor, nuclear factor {kappa}B (NF{kappa}B), may play a role, since the inhibitory effect of LPS and IL-1{beta} on LTP was attenuated by the NF{kappa}B inhibitor, SN50; consistently, LPS and IL-1{beta} led to activation of NF{kappa}B in entorhinal cortex. We suggest that one consequence of these LPS and IL-1{beta}-induced changes is a compromise in glutamate release in dentate gyrus, which was coupled with the inhibition of LTP. The evidence is consistent with the idea that the LPS-induced impairment in LTP is mediated by IL-1{beta} and is a consequence of activation of p38.


Received for publication, February 24, 2003

{ddagger} To whom correspondence should be addressed. Tel.: 353-1-6083794/6081019; Fax: 353-1-6793545; E-mail: aikelly{at}tcd.ie.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
N. Origlia, M. Righi, S. Capsoni, A. Cattaneo, F. Fang, D. M. Stern, J. X. Chen, A. M. Schmidt, O. Arancio, S. D. Yan, et al.
Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-{beta}-Mediated Cortical Synaptic Dysfunction
J. Neurosci., March 26, 2008; 28(13): 3521 - 3530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Clarke, A. Lyons, F. O'Connell, B. F. Deighan, C. E. Barry, N. G. Anyakoha, A. Nicolaou, and M. A. Lynch
A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain
J. Biol. Chem., January 25, 2008; 283(4): 1808 - 1817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Saika, T. Miyamoto, O. Yamanaka, T. Kato, Y. Ohnishi, K. C. Flanders, K. Ikeda, Y. Nakajima, W. W.-Y. Kao, M. Sato, et al.
Therapeutic Effect of Topical Administration of SN50, an Inhibitor of Nuclear Factor-{kappa}B, in Treatment of Corneal Alkali Burns in Mice
Am. J. Pathol., May 1, 2005; 166(5): 1393 - 1403.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-B. Zhu, A. M. Carneiro, W. R. Dostmann, W. A. Hewlett, and R. D. Blakely
p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process
J. Biol. Chem., April 22, 2005; 280(16): 15649 - 15658.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Srinivasan, J.-H. Yen, D. J. Joseph, and W. Friedman
Cell Type-Specific Interleukin-1{beta} Signaling in the CNS
J. Neurosci., July 21, 2004; 24(29): 6482 - 6488.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. A. LYNCH
Long-Term Potentiation and Memory
Physiol Rev, January 1, 2004; 84(1): 87 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.